Skip to main content
Clinical Trials/ISRCTN16971578
ISRCTN16971578Active, not recruitingUnknown

A randomized controlled study to evaluate a digital intervention for the treatment of adjustment disorders in adults

Elona Health GmbH0 sites158 target enrollmentStarted: July 6, 2023Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Active, not recruiting
Sponsor
Enrollment
158

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • All subjects must have been diagnosed with the following ICD-10 diagnosis:
  • F43.2: Adjustment disorders
  • Subjects further need to:
  • 1. Be at least 18 years old
  • 2. Possess sufficient German language skills (in writing and reading)
  • 3. Possess a smartphone (iOS or Android operating system) with internet access
  • 4. Provide signed and dated informed consent and be willing to comply with the protocol

Exclusion Criteria

  • All subjects without the inclusion ICD-10 diagnosis criteria, as well as subjects with the following ICD-10 diagnoses, are excluded:
  • F00-F09: Organic, including symptomatic, mental disorders
  • F10-F19 Mental and behavioural disorders due to psychoactive substance use (except F17.1, F17.2, F17.3)
  • F20-F29: Schizophrenia, schizotypal and delusional disorders
  • F30: Manic episode
  • F31.0, F31.1, F31.2, F31.5, F31.6, F31.8, F31.9: Bipolar disorder current hypomanic or manic episode
  • F32.3: Severe depressive episode with psychotic symptoms
  • F33.3: Recurrent depressive disorder, current episode severe with psychotic symptoms
  • 1. Subjects with acute suicidality (assessed via suicidality screening of the mini-DIPS at the initial screening)
  • 2. Subjects under the age of 18, subjects without any access to a smartphone (iOS or Android operating system) with internet access
  • 3. Subjects without German language proficiency
  • If a subject is currently enrolled or is planning to participate in a potentially confounding drug or device trial during the study, enrollment into this study needs to be pre-approved by the principal investigator.

Investigators

Sponsor
Elona Health GmbH

Similar Trials